FORESEE: a tool for the systematic comparison of translational drug response modeling pipelines
Preprint
- 11 February 2019
- preprint
- Published by PeerJ in PeerJ Preprints
Abstract
Translational models that utilize omics data generated in in vitro studies to predict the drug efficacy of anti-cancer compounds in patients are highly distinct, which complicates the benchmarking process for new computational approaches. In reaction to this, we introduce the uniFied translatiOnal dRug rESponsE prEdiction platform FORESEE, an open-source R-package. FORESEE not only provides a uniform data format for public cell line and patient data sets, but also establishes a standardized environment for drug response prediction pipelines, incorporating various state-of-the-art preprocessing methods, model training algorithms and validation techniques. The modular implementation of individual elements of the pipeline facilitates a straightforward development of combinatorial models, which can be used to re-evaluate and improve already existing pipelines as well as to develop new ones. Availability and Implementation: FORESEE is licensed under GNU General Public License v3.0 and available at https://github.com/JRC-COMBINE/FORESEE . Supplementary Information: Supplementary Files 1 and 2 provide detailed descriptions of the pipeline and the data preparation process, while Supplementary File 3 presents basic use cases of the package. Contact: schuppert@combine.rwth-aachen.deKeywords
All Related Versions
This publication has 17 references indexed in Scilit:
- Correlating chemical sensitivity and basal gene expression reveals mechanism of actionNature Chemical Biology, 2015
- rcellminer: exploring molecular profiles and drug response of the NCI-60 cell lines in RBioinformatics, 2015
- Harnessing Connectivity in a Large-Scale Small-Molecule Sensitivity DatasetCancer Discovery, 2015
- High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug responseNature Medicine, 2015
- Genomic signatures for paclitaxel and gemcitabine resistance in breast cancer derived by machine learningMolecular Oncology, 2015
- SYSTEMATIC ASSESSMENT OF ANALYTICAL METHODS FOR DRUG SENSITIVITY PREDICTION FROM CANCER CELL LINE DATA2013
- An Interactive Resource to Identify Cancer Genetic and Lineage Dependencies Targeted by Small MoleculesCell, 2013
- Systematic identification of genomic markers of drug sensitivity in cancer cellsNature, 2012
- Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomibBlood, 2006
- Patterns of Resistance and Incomplete Response to Docetaxel by Gene Expression Profiling in Breast Cancer PatientsJournal of Clinical Oncology, 2005